All News

New Collaboration to Evaluate Lower-Dose Gene Therapy Conditioning for Sickle Cell Disease

Jasper Therapeutics and Aruvant Sciences are studying the use of JSP191 used with ARU-1801 in patients with sickle cell disease.

Car T-Cell Therapy: The Future of Multiple Myeloma Treatment?

C. Ola Landgren, MD, PhD, discussed the role of CAR T-cell therapies in myltiple myeloma.

The Potential of CAR T-Cell Therapy for Multiple Myeloma

James Hoffman, MD, discussed the significance of the approval of ide-cel for patients with multiple myeloma.